Congress Asset Management CO Ligand Pharmaceuticals Inc Transaction History

Congress Asset Management CO

$12.9 Billion
Q1 2025

A detailed history of Congress Asset Management CO transactions in Ligand Pharmaceuticals Inc stock. As of the latest transaction made, Congress Asset Management CO holds 642,712 shares of LGND stock, worth $72.3 Million. This represents 0.54% of its overall portfolio holdings.

Number of Shares

642,712

Previous 621,482 3.42%

Holding current value

$72.3 Million

Previous $66.6 Million 3.87%

% of portfolio

0.54%

Previous 0.47%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 11, 2025	BUY	$105.14 - $122.23 $2.23 Million - $2.59 Million	21,230 Added 3.42%	642,712 $69.2 Million
Q4 2024 Jan 30, 2025	BUY	$99.95 - $129.9 $1.74 Million - $2.27 Million	17,444 Added 2.89%	621,482 $66.6 Million
Q3 2024 Oct 28, 2024	BUY	$82.7 - $110.11 $1.44 Million - $1.92 Million	17,414 Added 2.97%	604,038 $60.5 Million
Q2 2024 Aug 02, 2024	BUY	$68.53 - $87.91 $40.2 Million - $51.6 Million	586,624 New	586,624 $49.4 Million
Q4 2020 Jan 26, 2021	SELL	$80.55 - $106.05 $2.61 Million - $3.43 Million	-32,375 Closed	0 $0
Q3 2020 Nov 03, 2020	BUY	$89.56 - $126.72 $127,891 - $180,956	1,428 Added 4.61%	32,375 $3.09 Million
Q2 2020 Jul 23, 2020	BUY	$68.28 - $123.65 $44,723 - $80,990	655 Added 2.16%	30,947 $3.46 Million
Q1 2020 Apr 21, 2020	BUY	$63.37 - $107.88 $710,567 - $1.21 Million	11,213 Added 58.77%	30,292 $2.2 Million
Q4 2019 Feb 10, 2020	SELL	$96.94 - $113.59 $628,558 - $736,517	-6,484 Reduced 25.36%	19,079 $1.99 Million
Q3 2019 Nov 01, 2019	BUY	$86.25 - $120.16 $137,741 - $191,895	1,597 Added 6.66%	25,563 $2.55 Million
Q2 2019 Aug 07, 2019	BUY	$107.38 - $129.34 $173,418 - $208,884	1,615 Added 7.23%	23,966 $2.74 Million
Q1 2019 May 08, 2019	BUY	$105.93 - $142.47 $101,480 - $136,486	958 Added 4.48%	22,351 $2.81 Million
Q4 2018 Jan 25, 2019	SELL	$128.36 - $272.13 $5,776 - $12,245	-45 Reduced 0.21%	21,393 $2.9 Million
Q3 2018 Oct 26, 2018	SELL	$211.18 - $274.49 $85,950 - $111,717	-407 Reduced 1.86%	21,438 $5.89 Million
Q2 2018 Jul 25, 2018	BUY	$150.77 - $207.98 $152,579 - $210,475	1,012 Added 4.86%	21,845 $4.53 Million
Q1 2018 May 11, 2018	BUY	$138.63 - $182.62 $305,263 - $402,129	2,202 Added 11.82%	20,833 $3.44 Million
Q4 2017 Jan 30, 2018	BUY	$128.36 - $147.04 $484,687 - $555,223	3,776 Added 25.42%	18,631 $2.55 Million
Q3 2017 Oct 17, 2017	BUY	$120.91 - $137.94 $1.8 Million - $2.05 Million	14,855	14,855 $2.02 Million

Others Institutions Holding LGND

# of Institutions

280

Shares Held

19M

Call Options Held

9.5K

Put Options Held

8.1K

View Full List

About LIGAND PHARMACEUTICALS INC

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $1.9B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

More about LGND

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Congress Asset Management CO , based on Form 13F filings with the SEC.

News

Stay updated on Congress Asset Management CO with notifications on news.

Account

Congress Asset Management CO Ligand Pharmaceuticals Inc Transaction History